Exposure to ARVs in womb does not affect child's mental development, Canadians report

This article is more than 18 years old. Click here for more recent articles on this topic

A prospective, controlled study reported in the October edition of the journal Pediatrics shows that exposure to antiretrovirals in the womb did not affect the neurological development of children born to HIV-positive mothers, and that maternal use of substances such as cocaine and methadone may have a greater influence on neurological development.

Concerns have been raised about the possible harmful effects to infants of exposure to antiretroviral drugs during gestation or around the time of delivery. In particular, there are worries that antiretroviral drugs might affect neurological development, since brain development continues throughout pregnancy, and there have been reports of neural tube defects in a small number of children exposed to nucleoside analogues in the womb.

Researchers in Canada compared 39 children exposed to triple antiretroviral therapy in the womb with 24 children born to HIV-negative mothers with similar levels of substance abuse and hepatitis C infection as the HIV-positive mothers.

Glossary

control group

A group of participants in a trial who receive standard treatment, or no treatment at all, rather than the experimental treatment which is being tested. Also known as a control arm.

neurological

Relating to the brain or central nervous system.

p-value

The result of a statistical test which tells us whether the results of a study are likely to be due to chance and would not be confirmed if the study was repeated. All p-values are between 0 and 1; the most reliable studies have p-values very close to 0. A p-value of 0.001 means that there is a 1 in 1000 probability that the results are due to chance and do not reflect a real difference. A p-value of 0.05 means there is a 1 in 20 probability that the results are due to chance. When a p-value is 0.05 or below, the result is considered to be ‘statistically significant’. Confidence intervals give similar information to p-values but are easier to interpret. 

withdrawal

In the context of drugs or alcohol, withdrawal is when a person cuts out, or cuts back, on using the substance, also known as detoxification or detox. In a context of sexual risk reduction, it refers to the insertive partner in penetrative sex withdrawing before ejaculation. It is not a particularly effective way to lower the risk of HIV transmission or pregnancy.

prospective study

A type of longitudinal study in which people join the study and information is then collected on them for several weeks, months or years. 

Children in the exposed group were identified through the British Columbia provincial care programme for HIV-positive women, and were followed for 18 to 36 months after birth. All children had been exposed to a combination of three antiretroviral drugs for at least one week in the womb and to AZT during delivery and the neonatal period, and were HIV-negative.

Children in the control group were born to a cohort of mothers identified through a British Columbia hepatitis C vertical transmission study, in order to match the background risk factors for impaired neurodevelopment that might be present in mothers with HIV in the province. Half of the HIV-negative mothers had a history of injecting drug use.

The majority of HIV-positive mothers took a nevirapine-based triple combination during pregnancy; 13 took a protease inhibitor-based combination. The median duration of ART exposure during pregnancy was 17 weeks.

An increased risk of premature delivery has been associated with exposure to antiretroviral therapy during pregnancy in some studies, and antiretroviral-exposed infants had a significantly lower birth weight and gestational age in this study.

Children in the exposed group had a mean gestational age of 37.7 weeks at birth compared to 39 weeks in the control group, and 25% were born between 34 and 37 weeks of pregnancy, but only one case of delivery prior to 34 weeks was reported in the exposed group. The mean birth weight was 3028 g versus 3410 g in the control group.

The researchers used a widely accepted neurodevelopment measure (BSID-II) to measure children’s mental development index and psychomotor development index. Communication and socialisation were measured using the Vineland Adaptive Behaviour scales.

A significant difference was found in the mental development index, which was found to be significantly lower in the exposed group (94 vs 85, p=0.041). A greater proportion of exposed children scored at least one standard deviation below average (54% vs 25%).

Exposed children also had a lower score on the Vineland daily living index, which measures the ability of the child to carry out tasks associated with normal daily life, such as feeding.

However, when the researchers controlled for maternal substance use, no differences between the exposed and control groups remained, leading the researchers to suggest that any analysis of developmental problems in children exposed to antiretrovirals during pregnancy needs to take more account of the mother’s drug and alcohol use during pregnancy.

One-third of children in the exposed group had narcotic withdrawal syndrome at birth, compared to none of the control group, and perinatal complications such as foetal distress and required resuscitation were reported in 25% of exposed infants, compared to only one of the control group.

The mean scores of exposed children without maternal substance use were substantially closer to those of the control group than to those of exposed children of substance-using mothers, the researchers reported. In addition, children of exposed mothers who were also exposed to methadone had significantly lower mental development scores when compared to exposed children without methadone exposure (p=0.039).

“Overall we found that maternal substance use was a stronger predictor of a poor neurodevelopmental outcome than HAART exposure,” the researchers conclude.

Also, they note: “One-third of the children in this study experienced a change in the family’s status (such as placement in foster care or separation from the father) in the preceding year. Home environment during the first years of life plays an important role in a child’s neurodevelopment.”

The researchers conclude that with antiretrovirals being made available to much larger numbers of pregnant women in developing countries, studies of potential toxicities are essential, but these need to take into account substance exposure and social factors as well as treatment history.

References

Alimenti A et al. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Pediatrics 118 (4): 1139-45, 2006.